QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL04 IMMUNOSUPPRESSANTS
QL04A IMMUNOSUPPRESSANTS
QL04AA Selective immunosuppressants
QL04AA02 muromonab-CD3
QL04AA03 antilymphocyte immunoglobulin (horse)
QL04AA04 antithymocyte immunoglobulin (rabbit)
QL04AA06 mycophenolic acid
QL04AA10 sirolimus
QL04AA13 leflunomide
QL04AA15 alefacept
QL04AA18 everolimus
QL04AA19 gusperimus
QL04AA21 efalizumab
QL04AA22 abetimus
QL04AA23 natalizumab
QL04AA24 abatacept
QL04AA25 eculizumab
QL04AA26 belimumab
QL04AA27 fingolimod
QL04AA28 belatacept
QL04AA29 tofacitinib
QL04AA31 teriflunomide
QL04AA32 apremilast
QL04AA33 vedolizumab
QL04AA34 alemtuzumab
QL04AA35 begelomab
QL04AA36 ocrelizumab
QL04AA37 baricitinib
QL04AA38 ozanimod
QL04AA39 emapalumab
QL04AA40 cladribine
QL04AA41 imlifidase
QL04AA42 siponimod
QL04AA43 ravulizumab
QL04AA44 upadacitinib
QL04AA45 filgotinib
QL04AA46 itacitinib
QL04AA47 inebilizumab
QL04AA48 belumosudil
QL04AA49 peficitinib
QL04AA50 ponesimod
QL04AA51 anifrolumab
QL04AA52 ofatumumab
QL04AA53 teprotumumab
QL04AA54 pegcetacoplan
QL04AA55 sutimlimab
QL04AA56 deucravacitinib
QL04AA57 ublituximab
QL04AA58 efgartigimod alfa
QL04AA59 avacopan
Last updated: 2022-12-22